News | Radiation Oncology | February 02, 2023

Through its “A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research” program, awards will be given to outstanding female researchers at different stages in their careers, and the V Foundation will fund at least $8 million in grants

The V Foundation for Cancer Research has announced a new grant program aimed at increasing female representation and female-led innovation in cancer research.

The V Foundation for Cancer Research has announced a new grant program aimed at increasing female representation and female-led innovation in cancer research. Through its “A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research” program, awards will be given to outstanding female researchers at different stages in their careers, and the V Foundation will fund at least $8 million in grants. Photo credit: Getty Images


February 2, 2023 — The V Foundation, a top cancer research charity, has announced the establishment of a new grant program specifically aimed at increasing female representation and female-led innovation in cancer research. “A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research” is one of the very few gender-specific grant programs designed to address gender inequities in cancer research funding. Awards will be given to outstanding female researchers at different stages in their careers, and the V Foundation will fund at least $8 million in grants.

“By providing self-identified female investigators the necessary resources to begin and sustain impactful research and careers, ‘A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research’ will help address systemic gender disparities which have long existed and were further widened during the pandemic. These factors have kept women from fully contributing to the field of cancer research,” said Susanna F. Greer, Ph.D., the organization’s Chief Scientific Officer.

The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach and ESPN commentator. The V Foundation has funded over $310 million in game-changing cancer research grants nationwide through a competitive process strictly supervised by a world-class Scientific Advisory Committee. A statement announcing the new program noted that because the V Foundation has an endowment to cover administrative expenses, 100% of direct donations is awarded to cancer research and programs.

Persistent Gender Disparities Exist in The Field of Scientific Research

Compared to their male counterparts, women are paid less in comparable academic positions, receive lower startup funds for research with women scientists at some major institutes receiving 38% less in funding, and receive fewer awards from National Institutes of Health (NIH) grant programs at all points in their careers.

Additionally, female researchers shoulder an inequitable load as caregivers which was made even more apparent during the past few years of the pandemic. A survey of researchers found that female scientists and those with young children experienced a substantial decline in time devoted to research due to COVID-19. Given that time is of the essence in research, especially for scientists in the early stages of their careers, the losses experienced during the pandemic could have lasting effects on the number of women represented in cancer research.

To counter the historical gender disparities and pandemic-related career setbacks women researchers have experienced, the V Foundation will be awarding two separate grants as part of the inaugural "A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research," including:

The V Scholar Award will be awarded to early career investigators whose research increases our understanding of cancer biology or translational-type research that improves cancer detection, prevention, treatment, and survivorship; winners will receive $600,000 in funding over three years.

The Translational Research Award will be awarded to investigators who pursue cancer research that moves a novel strategy from the laboratory to a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms; winners will receive $800,000 in funding over four years.

“These female-specific grants expand on the V Foundation’s work to level the playing field by providing funds to support the research of all-star women scientists and those of color whose contributions are desperately needed to help us accelerate ‘Victory Over Cancer,’” said Shane Jacobson, CEO, V Foundation. “This year marks the 30th anniversary of the V Foundation, and from day one we have always been committed to female-led cancer research,” added Jacobson. The organization, a 501 (c)(3) nonprofit, is commemorating its 30th anniversary with a Gala to be held at the Reynolds Coliseum in Raleigh, NC, on June 3, 2023.

V Foundation grants are awarded to researchers nominated by National Cancer Institute (NCI)-designated Cancer Centers and other exceptional research institutions and then selected by the Foundation’s Scientific Advisory Board.

Institutional nominations for “A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research” must be submitted to the V Foundation by February 15, 2023; candidate applications are due to the Foundation on March 16, 2023.

For more information: [email protected]


Related Content

News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
Subscribe Now